Xiaoli Wu, Mingyue Li, Yanfang Zhang, Boyun Liang, Junming Shi, Yaohui Fang, Zhengyuan Su, Mengmeng Li, Wenjing Zhang, Ling Xu, Jun Wang, Qiaoli Wu, Shuang Tang, Hualin Wang, Tao Zhang, Cheng Peng, Xin Zheng, Fei Deng and Shu Shen. Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes[J]. Virologica Sinica, 2021, 36(2): 300-310. doi: 10.1007/s12250-020-00289-0
Citation: Xiaoli Wu, Mingyue Li, Yanfang Zhang, Boyun Liang, Junming Shi, Yaohui Fang, Zhengyuan Su, Mengmeng Li, Wenjing Zhang, Ling Xu, Jun Wang, Qiaoli Wu, Shuang Tang, Hualin Wang, Tao Zhang, Cheng Peng, Xin Zheng, Fei Deng, Shu Shen. Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes .VIROLOGICA SINICA, 2021, 36(2) : 300-310.  http://dx.doi.org/10.1007/s12250-020-00289-0

发热板血小板减少综合征病毒SFTSV系统发育分析揭示了新的重组事件与迁移路线

  • 通讯作者: 郑昕, xinsunshine1011@aliyun.com, ORCID: http://orcid.org/0000-0003-1209-5281
    ; 邓菲, df@wh.iov.cn, ORCID: http://orcid.org/0000-0002-5385-083X
    ; 沈姝, shenshu@wh.iov.cn, ORCID: http://orcid.org/0000-0002-0013-5365
  • 收稿日期: 2020-05-08
    录用日期: 2020-07-13
    出版日期: 2020-09-22
  • 发热伴血小板减少综合症病毒(SFTSV)会引起人类严重的发热性疾病,最初在中国的中部和东部省份,以及后来在日本和韩国发现了该病毒。湖北省是中国中部主要的SFTS流行地区之一。这项研究报告了2017年从湖北省患者中分离出11株新的SFTSV毒株。基于包括该新毒株在内的SFTSV片段的完整编码序列,进行了广泛的系统发育分析。本研究表明,目前湖北省有五种不同基因型的SFTSV在流传,SFTSV毒株有15种重排模式,并且每种基因型的SFTSV相关的迁移途径较之前更为复杂。与之前报道湖北省SFTSV的进化事件独立于其他流行地区相比,本研究发现湖北省参与了更多的SFTSV的进化事件。同时本研究通过比较每种基因型内的SFTSV序列同一性和不同基因型间的SFTSV序列(以基因型C1作为代表性毒株)同一性,发现SFTSV毒株的进一步分化。随后分析SFSTV毒株蛋白氨基酸在基因型,毒株或簇上存在的差异,分析可能与SFTSV毒株/基因型的不同生物学活性有关。总之,我们分析了湖北省SFTSV系统发育进化的现状,并讨论了与SFTSV进化相关的可能事件。为深入了解SFTSV进化提供了基础,引起人们在未来研究中选择适当的SFTSV毒株的关注。

Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes

  • Corresponding author: Xin Zheng, xinsunshine1011@aliyun.com Fei Deng, df@wh.iov.cn Shu Shen, shenshu@wh.iov.cn
  • ORCID: http://orcid.org/0000-0003-1209-5281; http://orcid.org/0000-0002-5385-083X; http://orcid.org/0000-0002-0013-5365
  • Received Date: 08 May 2020
    Accepted Date: 13 July 2020
    Published Date: 22 September 2020
  • Severe fever with thrombocytopenia syndrome virus (SFTSV), the causative agent of a febrile human disease, was first identified from central and eastern provinces in China, and later in Japan and South Korea. Hubei Province is one of the major SFTS epidemic areas in the central part of China. This study reported the isolation of 11 new SFTSV strains from patients in Hubei Province collected in 2017. Extensive phylogenetic analyses were conducted based on the complete coding sequences of SFTSV segments including the new strains. It was suggested that five different SFTSV genotypes were circulating in Hubei, and 15 reassortment patterns and migration pathways correlated with each genotype were identified, which was more than previously recognized. Hubei Province was more involved in the evolutionary events of SFTSV than that previously thought in which the evolutionary events of SFTSV were reported to be independent from those in other epidemic regions. Further divergence of SFTSV strains was suggested by pairwise comparison of SFTSV sequences from each genotype and sequence identity normalized to representative strain in genotype C1. Subsequently, amino acid variations specific for genotype(s), strain(s), or cluster(s) were inspected, which may be related to differential biological activity of SFTSV strains/genotypes. In conclusion, we analyzed the current status of SFTSV phylogeny in Hubei Province and discussed the possible events correlated to SFTSV evolution. It provided an in-depth insight into SFTSV evolution, raising concerns for the use of proper SFTSV strains in future studies.


  • 加载中
    1. Halldorssona S, Behrensb A, Harlosa K, Huiskonena J, Elliottc R, Crispinb M, Brennanc B, Bowdena T (2016) Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion. PNAS 113:7154-7159
        doi: 10.1073/pnas.1603827113

    2. Hu B, Cai K, Liu M, Li W, Xu J, Qiu F, Zhan J (2018) Laboratory detection and molecular phylogenetic analysis of severe fever with thrombocytopenia syndrome virus in Hubei Province, central China. Arch Virol 163:3243-3254
        doi: 10.1007/s00705-018-3993-5

    3. Kim K, Kim J, Ko M, Chun J, Kim H, Kim S, Min J, Park W, Oh M, Chung J (2019) An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLoS Pathog 15:e1007375
        doi: 10.1371/journal.ppat.1007375

    4. Lee S, Cho Y, Jeong H, Kim W, Son K, Kim J, Oh S, Jheong W, Chaeb J (2019) Complete genome sequences of two severe fever with thrombocytopenia syndrome virus strains isolated from a human and a dog in the republic of Korea. Microbiol Resour Announc 8:e01695-18

    5. Lv Q, Zhang H, Tian L, Zhang R, Zhang Z, Li J, Tong Y, Fan H, Carr M, Shi W (2017) Novel sub-lineages, recombinants and reassortants of severe fever with thrombocytopenia syndrome virus. Ticks Tick Borne Dis 8:385-390
        doi: 10.1016/j.ttbdis.2016.12.015

    6. Mahmood N, Khurram M, Khan M, Umar M, Jalil A, Sharif S (2019) Characteristics of probable severe fever with thrombocytopenia syndrome patients:a perspective study from Pakistan. Int J Med Devel Ctries 3:8

    7. McMullan L, Folk S, Kelly A, MacNeil A, Goldsmith C, Metcalfe M, Batten B, Albariño C, Zaki S, Rollin P, Nicholson W, Nichol S (2012) A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med 367:834-841
        doi: 10.1056/NEJMoa1203378

    8. Park E, Shimojima M, Nagata N, Ami Y, Yoshikawa T, Iwata-Yoshikawa N, Fukushi S, Watanabe S, Kurosu T, Kataoka M, Okutani A, Kimura M, Imaoka K, Hanaki K, Suzuki T, Hasegawa H, Saijo M, Maeda K, Morikawa S (2019) Severe fever with thrombocytopenia syndrome phlebovirus causes lethal viral hemorrhagic fever in cats. Sci Rep 9:11990
        doi: 10.1038/s41598-019-48317-8

    9. Reece L, Beasley D, Milligan G, Sarathy V, Barrett A (2018) Current status of severe fever with thrombocytopenia syndrome vaccine development. Curr Opin Virol 29:72-78
        doi: 10.1016/j.coviro.2018.03.005

    10. Shi J, Hu S, Liu X, Yang J, Liu D, Wu L, Wang H, Hu Z, Deng F, Shen S (2017) Migration, recombination, and reassortment are involved in the evolution of severe fever with thrombocytopenia syndrome bunyavirus. Infect Genet Evol 47:109-117
        doi: 10.1016/j.meegid.2016.11.015

    11. Sun J, Lu L, Wu H, Yang J, Ren J, Liu Q (2017) The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011-2016. Sci Rep 7:9236
        doi: 10.1038/s41598-017-08042-6

    12. Tani H, Kawachi K, Kimura M, Taniguchi S, Shimojima M, Fukushi S, Igarashi M, Morikawa S, Saijo M (2019) Identification of the amino acid residue important for fusion of severe fever with thrombocytopenia syndrome virus glycoprotein. Virology 535:102-110
        doi: 10.1016/j.virol.2019.06.014

    13. Tran X, Yun Y, Le Van An SHK, Kim S, Thao N, Man P, Yoo J, Heo S, Cho N, Lee K (2019) Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg Infect Dis 25:1029-1031
        doi: 10.3201/eid2505.181463

    14. Wu Y, Zhu Y, Gao F, Jiao Y, Oladejo BO, Chai Y, Bi Y, Lu S, Dong M, Zhang C, Huang G, Wong G, Li N, Zhang Y, Li Y, Feng WH, Shi Y, Liang M, Zhang R, Qi J, Gao GF (2017) Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc Natl Acad Sci USA 114:E7564-E7573
        doi: 10.1073/pnas.1705176114

    15. Yang L, Zhao Z, Hou G, Zhang C, Liu J, Xu L, Li W, Tan Z, Tu C, He B (2019) Genomes and seroprevalence of severe fever with thrombocytopenia syndrome virus and Nairobi sheep disease virus in Haemaphysalis longicornis ticks and goats in Hubei, China. Virology 529:234-245
        doi: 10.1016/j.virol.2019.01.026

    16. Yoshikawa T, Shimojima M, Fukushi S, Tani H, Fukuma A, Taniguchi S, Singh H, Suda Y, Shirabe K, Toda S, Shimazu Y, Nomachi T, Gokuden M, Morimitsu T, Ando K, Yoshikawa A, Kan M, Uramoto M, Osako H, Kida K, Takimoto H, Kitamoto H, Terasoma F, Honda A, Maeda K, Takahashi T, Yamagishi T, Oishi K, Morikawa S, Saijo M (2015) Phylogenetic and geographic relationships of severe fever with thrombocytopenia syndrome virus in China, South Korea, and Japan. J Infect Dis 212:889-898
        doi: 10.1093/infdis/jiv144

    17. Yu X, Liang M, Zhang S, Liu Y, Li J, Sun Y, Zhang L, Zhang Q, Popov V, Li C, Qu J, Li Q, Zhang Y, Hai R, Wu W, Wang Q, Zhan F, Wang X, Kan B, Wang S, Wan K, Jing H, Lu J, Yin W, Zhou H, Guan X, Liu J, Bi Z, Liu G, Ren J, Wang H, Zhao Z, Song J, He J, Wan T, Zhang J, Fu X, Sun L, Dong X, Feng Z, Yang W, Hong T, Zhang Y, Walker D, Wang Y, Li DX (2011) Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 364:1523-1532
        doi: 10.1056/NEJMoa1010095

    18. Zhan J, Wang Q, Cheng J, Hu B, Li J, Zhan F, Song Y, Guo D (2017) Current status of severe fever with thrombocytopenia syndrome in China. Virol Sin 32:51-62
        doi: 10.1007/s12250-016-3931-1

    19. Zhang Y, Zhou D, Xiong Y, Chen X, He Y, Sun Q, Yu B, Li J, Dai Y, Tian J, Qin X, Jin D, Cui Z, Luo X, Li W, Lu S, Wang W, Peng J, Guo W, Li M, Li Z, Zhang S, Chen C, Wang Y, Xu J (2011) Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Chin J Epidemiol 32: 209-220 (in Chinese)

    20. Zhang Y, Shen S, Shi J, Su Z, Li M, Zhang W, Li M, Hu Z, Peng C, Zheng X, Deng F (2017) Isolation, characterization, and phylogenic analysis of three new severe fever with thrombocytopenia syndrome bunyavirus strains derived from Hubei Province, China. Virol Sin 32:89-96
        doi: 10.1007/s12250-017-3953-3

  • 加载中
  • 10.1007s12250-020-00289-0-ESM1.pdf
    10.1007s12250-020-00289-0-ESM2.xlsx

Figures(5) / Tables(1)

Article Metrics

Article views(5279) PDF downloads(38) Cited by(0)

Related
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes

      Corresponding author: Xin Zheng, xinsunshine1011@aliyun.com
      Corresponding author: Fei Deng, df@wh.iov.cn
      Corresponding author: Shu Shen, shenshu@wh.iov.cn
    • 1. State Key Laboratory of Virology and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
    • 2. University of Chinese Academy of Sciences, Beijing 100049, China
    • 3. Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan 430022, China

    Abstract: 

    Severe fever with thrombocytopenia syndrome virus (SFTSV), the causative agent of a febrile human disease, was first identified from central and eastern provinces in China, and later in Japan and South Korea. Hubei Province is one of the major SFTS epidemic areas in the central part of China. This study reported the isolation of 11 new SFTSV strains from patients in Hubei Province collected in 2017. Extensive phylogenetic analyses were conducted based on the complete coding sequences of SFTSV segments including the new strains. It was suggested that five different SFTSV genotypes were circulating in Hubei, and 15 reassortment patterns and migration pathways correlated with each genotype were identified, which was more than previously recognized. Hubei Province was more involved in the evolutionary events of SFTSV than that previously thought in which the evolutionary events of SFTSV were reported to be independent from those in other epidemic regions. Further divergence of SFTSV strains was suggested by pairwise comparison of SFTSV sequences from each genotype and sequence identity normalized to representative strain in genotype C1. Subsequently, amino acid variations specific for genotype(s), strain(s), or cluster(s) were inspected, which may be related to differential biological activity of SFTSV strains/genotypes. In conclusion, we analyzed the current status of SFTSV phylogeny in Hubei Province and discussed the possible events correlated to SFTSV evolution. It provided an in-depth insight into SFTSV evolution, raising concerns for the use of proper SFTSV strains in future studies.